Pacira BioSciences (PCRX) Finished Goods (2011 - 2014)

Pacira BioSciences' Finished Goods history runs 4 years deep, the most recent figure standing at $6.4 million for Q2 2014.

• On a quarterly basis, Finished Goods rose 49.0% year-over-year to $6.4 million in Q2 2014; TTM through Jun 2014 was $6.4 million, a 49.0% increase from a year earlier, with the FY2013 full-year figure at $3.9 million, up 95.64% from the prior year.
• Finished Goods advanced to $6.4 million in Q2 2014 per PCRX's latest filing, from $3.9 million in the prior quarter.
• Across five years, Finished Goods topped out at $6.4 million in Q3 2012 and bottomed at $287000.0 in Q4 2011.
• The 4-year median for Finished Goods is $4.1 million (2013), against an average of $3.9 million.
• Across the five-year window, Finished Goods jumped 602.79% in 2012 and slipped 5.81% in 2013, its largest moves.
• Year by year, Finished Goods stood at $287000.0 in 2011, then soared by 602.79% to $2.0 million in 2012, then surged by 95.64% to $3.9 million in 2013, then surged by 61.05% to $6.4 million in 2014.
• Per Business Quant, the three latest PCRX Finished Goods figures stand at $6.4 million (Q2 2014), $3.9 million (Q4 2013), and $4.3 million (Q2 2013).